Review



daptomycin  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Thermo Fisher daptomycin
    Daptomycin, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/daptomycin/pmc12771081-49-1-2?v=Thermo+Fisher
    Average 94 stars, based on 1 article reviews
    daptomycin - by Bioz Stars, 2026-08
    94/100 stars

    Images



    Similar Products

    94
    Thermo Fisher daptomycin
    Daptomycin, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/daptomycin/pmc12771081-49-1-2?v=Thermo+Fisher
    Average 94 stars, based on 1 article reviews
    daptomycin - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    86
    Tokyo Chemical Industry daptomycin
    Daptomycin, supplied by Tokyo Chemical Industry, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/daptomycin/pm42321333-75-0-4?v=Tokyo+Chemical+Industry
    Average 86 stars, based on 1 article reviews
    daptomycin - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    86
    Eli Lilly daptomycin
    Daptomycin, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/daptomycin/pm42303174-27-2-6?v=Eli+Lilly
    Average 86 stars, based on 1 article reviews
    daptomycin - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    94
    Thermo Fisher bodipy 493 503
    ( A ) Binding of <t>BODIPY-labeled</t> daptomycin (BODIPY-Dap) in the previously determined subinhibitory concentration of 7.81 µg/mL to the S. capitis NRCS-A isolate ScSK1 (light blue) and the non-invasive S. capitis DSM6717 (dark blue). Bacterial cells were incubated with BODIPY-Dap and analyzed by flow cytometry (FITC channel) at 0 h, 0.5 h, 1 h, and 2 h. Statistical analysis was performed using two-way ANOVA with Šidák’s multiple-comparisons test to compare BODIPY-Dap binding between strains at each time point ( P < 0.05, * P < 0.01, ** P < 0.001). Data are shown as mean ± SD from at least four independent experiments. ( B ) Fluorescence microscopy of S. capitis strains DSM6717 and ScSK1 after incubation with BODIPY-Dap for 0, 10, 30, and 60 min. Representative images were acquired on a Zeiss LSM 800 confocal microscope using a 100× objective. Scale bar, 2 µm.
    Bodipy 493 503, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/daptomycin/pmc13148029-69-0-3?v=Thermo+Fisher
    Average 94 stars, based on 1 article reviews
    bodipy 493 503 - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    86
    Liofilchem daptomycin
    <t>Daptomycin</t> and vancomycin susceptibility of S. capitis NRCS-A isolates (ScSK) from our local collection as determined by MIC test strip. MICs of ( A ) daptomycin and ( B ) vancomycin are shown. Black lines indicate cut-off concentrations for resistance: 1 μg/mL for daptomycin, 2 μg/mL for vancomycin reduced susceptibility (cut-off for S. aureus ), and 4 μg/mL for vancomycin resistance (EUCAST definition, v15.0 of 2025). The S. aureus SA113 WT and SA113 ∆ mprF (gray), which is more susceptible to daptomycin and vancomycin, were used as controls. NRCS-A isolates (light blue) were compared with non-invasive S. capitis strain DSM6717 (dark blue) and the S. capitis bloodstream isolate from a toddler’s catheter sepsis (ScSK11, turquoise). The mean ± SEM of at least three independent experiments is shown.
    Daptomycin, supplied by Liofilchem, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/daptomycin/pmc13148029-61-5-8?v=Liofilchem
    Average 86 stars, based on 1 article reviews
    daptomycin - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    86
    Apollo Scientific Ltd daptomycin lipopeptide
    <t>Daptomycin</t> and vancomycin susceptibility of S. capitis NRCS-A isolates (ScSK) from our local collection as determined by MIC test strip. MICs of ( A ) daptomycin and ( B ) vancomycin are shown. Black lines indicate cut-off concentrations for resistance: 1 μg/mL for daptomycin, 2 μg/mL for vancomycin reduced susceptibility (cut-off for S. aureus ), and 4 μg/mL for vancomycin resistance (EUCAST definition, v15.0 of 2025). The S. aureus SA113 WT and SA113 ∆ mprF (gray), which is more susceptible to daptomycin and vancomycin, were used as controls. NRCS-A isolates (light blue) were compared with non-invasive S. capitis strain DSM6717 (dark blue) and the S. capitis bloodstream isolate from a toddler’s catheter sepsis (ScSK11, turquoise). The mean ± SEM of at least three independent experiments is shown.
    Daptomycin Lipopeptide, supplied by Apollo Scientific Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/daptomycin/pm42107309-82-2-24?v=Apollo+Scientific+Ltd
    Average 86 stars, based on 1 article reviews
    daptomycin lipopeptide - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    86
    Novartis daptomycin dap
    <t>Daptomycin</t> and vancomycin susceptibility of S. capitis NRCS-A isolates (ScSK) from our local collection as determined by MIC test strip. MICs of ( A ) daptomycin and ( B ) vancomycin are shown. Black lines indicate cut-off concentrations for resistance: 1 μg/mL for daptomycin, 2 μg/mL for vancomycin reduced susceptibility (cut-off for S. aureus ), and 4 μg/mL for vancomycin resistance (EUCAST definition, v15.0 of 2025). The S. aureus SA113 WT and SA113 ∆ mprF (gray), which is more susceptible to daptomycin and vancomycin, were used as controls. NRCS-A isolates (light blue) were compared with non-invasive S. capitis strain DSM6717 (dark blue) and the S. capitis bloodstream isolate from a toddler’s catheter sepsis (ScSK11, turquoise). The mean ± SEM of at least three independent experiments is shown.
    Daptomycin Dap, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/daptomycin/pm42041290-232-0-8?v=Novartis
    Average 86 stars, based on 1 article reviews
    daptomycin dap - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Binding of BODIPY-labeled daptomycin (BODIPY-Dap) in the previously determined subinhibitory concentration of 7.81 µg/mL to the S. capitis NRCS-A isolate ScSK1 (light blue) and the non-invasive S. capitis DSM6717 (dark blue). Bacterial cells were incubated with BODIPY-Dap and analyzed by flow cytometry (FITC channel) at 0 h, 0.5 h, 1 h, and 2 h. Statistical analysis was performed using two-way ANOVA with Šidák’s multiple-comparisons test to compare BODIPY-Dap binding between strains at each time point ( P < 0.05, * P < 0.01, ** P < 0.001). Data are shown as mean ± SD from at least four independent experiments. ( B ) Fluorescence microscopy of S. capitis strains DSM6717 and ScSK1 after incubation with BODIPY-Dap for 0, 10, 30, and 60 min. Representative images were acquired on a Zeiss LSM 800 confocal microscope using a 100× objective. Scale bar, 2 µm.

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Polygenic, cell-envelope adaptations drive high-frequency daptomycin resistance in Staphylococcus capitis NRCS-A from neonatal sepsis and NEC

    doi: 10.1128/aac.01414-25

    Figure Lengend Snippet: ( A ) Binding of BODIPY-labeled daptomycin (BODIPY-Dap) in the previously determined subinhibitory concentration of 7.81 µg/mL to the S. capitis NRCS-A isolate ScSK1 (light blue) and the non-invasive S. capitis DSM6717 (dark blue). Bacterial cells were incubated with BODIPY-Dap and analyzed by flow cytometry (FITC channel) at 0 h, 0.5 h, 1 h, and 2 h. Statistical analysis was performed using two-way ANOVA with Šidák’s multiple-comparisons test to compare BODIPY-Dap binding between strains at each time point ( P < 0.05, * P < 0.01, ** P < 0.001). Data are shown as mean ± SD from at least four independent experiments. ( B ) Fluorescence microscopy of S. capitis strains DSM6717 and ScSK1 after incubation with BODIPY-Dap for 0, 10, 30, and 60 min. Representative images were acquired on a Zeiss LSM 800 confocal microscope using a 100× objective. Scale bar, 2 µm.

    Article Snippet: BODIPY 493/503 (4,4-Difluoro-1,3,5,7,8-Pentamethyl-4-Bora-3a,4a-Diaza-s-Indacen) (Invitrogen/Thermo-Fisher, D3922) labeling of daptomycin was performed as described previously ( , ).

    Techniques: Binding Assay, Labeling, Concentration Assay, Incubation, Flow Cytometry, Fluorescence, Microscopy

    Daptomycin and vancomycin susceptibility of S. capitis NRCS-A isolates (ScSK) from our local collection as determined by MIC test strip. MICs of ( A ) daptomycin and ( B ) vancomycin are shown. Black lines indicate cut-off concentrations for resistance: 1 μg/mL for daptomycin, 2 μg/mL for vancomycin reduced susceptibility (cut-off for S. aureus ), and 4 μg/mL for vancomycin resistance (EUCAST definition, v15.0 of 2025). The S. aureus SA113 WT and SA113 ∆ mprF (gray), which is more susceptible to daptomycin and vancomycin, were used as controls. NRCS-A isolates (light blue) were compared with non-invasive S. capitis strain DSM6717 (dark blue) and the S. capitis bloodstream isolate from a toddler’s catheter sepsis (ScSK11, turquoise). The mean ± SEM of at least three independent experiments is shown.

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Polygenic, cell-envelope adaptations drive high-frequency daptomycin resistance in Staphylococcus capitis NRCS-A from neonatal sepsis and NEC

    doi: 10.1128/aac.01414-25

    Figure Lengend Snippet: Daptomycin and vancomycin susceptibility of S. capitis NRCS-A isolates (ScSK) from our local collection as determined by MIC test strip. MICs of ( A ) daptomycin and ( B ) vancomycin are shown. Black lines indicate cut-off concentrations for resistance: 1 μg/mL for daptomycin, 2 μg/mL for vancomycin reduced susceptibility (cut-off for S. aureus ), and 4 μg/mL for vancomycin resistance (EUCAST definition, v15.0 of 2025). The S. aureus SA113 WT and SA113 ∆ mprF (gray), which is more susceptible to daptomycin and vancomycin, were used as controls. NRCS-A isolates (light blue) were compared with non-invasive S. capitis strain DSM6717 (dark blue) and the S. capitis bloodstream isolate from a toddler’s catheter sepsis (ScSK11, turquoise). The mean ± SEM of at least three independent experiments is shown.

    Article Snippet: Therefore, MIC test strips for daptomycin and vancomycin (Liofilchem) were applied on MHB agar plates and analyzed after 24 h incubation at 37°C according to the manufacturer’s protocol.

    Techniques: Stripping Membranes

    ( A ) Binding of BODIPY-labeled daptomycin (BODIPY-Dap) in the previously determined subinhibitory concentration of 7.81 µg/mL to the S. capitis NRCS-A isolate ScSK1 (light blue) and the non-invasive S. capitis DSM6717 (dark blue). Bacterial cells were incubated with BODIPY-Dap and analyzed by flow cytometry (FITC channel) at 0 h, 0.5 h, 1 h, and 2 h. Statistical analysis was performed using two-way ANOVA with Šidák’s multiple-comparisons test to compare BODIPY-Dap binding between strains at each time point ( P < 0.05, * P < 0.01, ** P < 0.001). Data are shown as mean ± SD from at least four independent experiments. ( B ) Fluorescence microscopy of S. capitis strains DSM6717 and ScSK1 after incubation with BODIPY-Dap for 0, 10, 30, and 60 min. Representative images were acquired on a Zeiss LSM 800 confocal microscope using a 100× objective. Scale bar, 2 µm.

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Polygenic, cell-envelope adaptations drive high-frequency daptomycin resistance in Staphylococcus capitis NRCS-A from neonatal sepsis and NEC

    doi: 10.1128/aac.01414-25

    Figure Lengend Snippet: ( A ) Binding of BODIPY-labeled daptomycin (BODIPY-Dap) in the previously determined subinhibitory concentration of 7.81 µg/mL to the S. capitis NRCS-A isolate ScSK1 (light blue) and the non-invasive S. capitis DSM6717 (dark blue). Bacterial cells were incubated with BODIPY-Dap and analyzed by flow cytometry (FITC channel) at 0 h, 0.5 h, 1 h, and 2 h. Statistical analysis was performed using two-way ANOVA with Šidák’s multiple-comparisons test to compare BODIPY-Dap binding between strains at each time point ( P < 0.05, * P < 0.01, ** P < 0.001). Data are shown as mean ± SD from at least four independent experiments. ( B ) Fluorescence microscopy of S. capitis strains DSM6717 and ScSK1 after incubation with BODIPY-Dap for 0, 10, 30, and 60 min. Representative images were acquired on a Zeiss LSM 800 confocal microscope using a 100× objective. Scale bar, 2 µm.

    Article Snippet: Therefore, MIC test strips for daptomycin and vancomycin (Liofilchem) were applied on MHB agar plates and analyzed after 24 h incubation at 37°C according to the manufacturer’s protocol.

    Techniques: Binding Assay, Labeling, Concentration Assay, Incubation, Flow Cytometry, Fluorescence, Microscopy

    DAP-R evolution of S. capitis NRCS-A (ScSK4) in light blue compared to non-invasive S. capitis (DSM6717) in dark blue, S. aureus (USA300) in gray, and S. epidermidis (SeSK1) in white. Strains were grown without ( A ) or with ( B ) daptomycin pressure or ( C ) vancomycin pressure in MHB for 24 h followed by daptomycin MIC determination after each passage via E-tests. Black lines indicate cut-off concentrations for daptomycin resistance at 1 μg/mL (EUCAST definition, v15.0 of 2025). The black arrows highlight the passaging days on which bacterial strains evolved a DAP-R phenotype.

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Polygenic, cell-envelope adaptations drive high-frequency daptomycin resistance in Staphylococcus capitis NRCS-A from neonatal sepsis and NEC

    doi: 10.1128/aac.01414-25

    Figure Lengend Snippet: DAP-R evolution of S. capitis NRCS-A (ScSK4) in light blue compared to non-invasive S. capitis (DSM6717) in dark blue, S. aureus (USA300) in gray, and S. epidermidis (SeSK1) in white. Strains were grown without ( A ) or with ( B ) daptomycin pressure or ( C ) vancomycin pressure in MHB for 24 h followed by daptomycin MIC determination after each passage via E-tests. Black lines indicate cut-off concentrations for daptomycin resistance at 1 μg/mL (EUCAST definition, v15.0 of 2025). The black arrows highlight the passaging days on which bacterial strains evolved a DAP-R phenotype.

    Article Snippet: Therefore, MIC test strips for daptomycin and vancomycin (Liofilchem) were applied on MHB agar plates and analyzed after 24 h incubation at 37°C according to the manufacturer’s protocol.

    Techniques: Passaging